Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
ClinicalTrials.gov: Glioma OR Astrocytoma OR Oligodendroglioma | Other terms: IDH Mutation | Interventional, Expanded Access studies | Last update posted in the last 14 days
Get the latest updates from ClinicalTrials.gov: Glioma OR Astrocytoma OR Oligodendroglioma | Other terms: IDH Mutation | Interventional, Expanded Access studies | Last update posted in the last 14 days directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 10 hours ago
VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations
4 days ago
Conditions: Brain Cancer Interventions: Drug: Vorasidenib; Drug: Lomustine Sponsors: Megan Mantica; Institut...
Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma
5 days ago
Conditions: IDH1-mutant Glioma; IDH2-mutant Glioma Interventions: Drug: Vorasidenib; Drug: Temozolomide (TMZ) Sponsors...
Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation
5 days ago
Conditions: Residual or Recurrent Grade 2 IDH Mutant Glioma Interventions: Drug: Vorasidenib...
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
6 days ago
Conditions: Brain Tumor; Cancer Interventions: Drug: Zotiraciclib Sponsors: National Cancer Institute (NCI)...
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
11 days ago
Conditions: Glioma; Gliomas; High Grade Glioma; Malignant Glioma; Low Grade Glioma Interventions...
A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden
11 days ago
Conditions: Astrocytoma, IDH-Mutant, Grade 4; Diffuse Glioma; Glioblastoma, IDH-Wildtype; Secondary Glioblastoma Interventions...
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
11 days ago
Conditions: Recurrent Ependymoma; Recurrent Ewing Sarcoma; Recurrent Hepatoblastoma; Recurrent Langerhans Cell Histiocytosis...
Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma
13 days ago
Conditions: Adult Gliomas, Mixed Interventions: Drug: Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)...
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
14 days ago
Conditions: Anaplastic Astrocytoma; Anaplastic Oligoastrocytoma; Anaplastic Oligodendroglioma; Diffuse Astrocytoma; Glioma; Oligoastrocytoma; Oligodendroglioma...
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
18 days ago
Conditions: Glioma; Gliomas; High Grade Glioma; Malignant Glioma; Low Grade Glioma Interventions...
Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
18 days ago
Conditions: Recurrent CNS Tumors; Brain Cancer; Gliomas; IDH-wildtype Gliomas; IDH-mutant Gliomas; Rare...
Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma
27 days ago
Conditions: Recurrent Glioblastoma, IDH-Wildtype; Recurrent Gliosarcoma; Recurrent WHO Grade 4 Glioma Interventions...